PT  - JOURNAL ARTICLE
AU  - Merel J l’Ami
AU  - Charlotte L M Krieckaert
AU  - Michael T Nurmohamed
AU  - Ronald F van Vollenhoven
AU  - Theo Rispens
AU  - Maarten Boers
AU  - Gerrit Jan Wolbink
TI  - Response to: Comment on l’Ami <em>et al</em> titled ‘Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial’ by den Broeder <em>et al</em>
AID  - 10.1136/annrheumdis-2017-212602
DP  - 2017 Nov 11
TA  - Annals of the Rheumatic Diseases
PG  - annrheumdis-2017-212602
4099  - http://ard.bmj.com/content/early/2017/11/13/annrheumdis-2017-212602.short
4100  - http://ard.bmj.com/content/early/2017/11/13/annrheumdis-2017-212602.full